Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
Objective To investigate the therapeutic efficacy of artesunate (AS) on polycystic ovary syndrome (PCOS) in mice and explore the potential mechanism primarily. Methods Twenty-five female C57BL/6J mice were randomly divided into Control group, model group (PCOS group), low- and high-dose AS group...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Army Medical University
2025-02-01
|
| Series: | 陆军军医大学学报 |
| Subjects: | |
| Online Access: | https://aammt.tmmu.edu.cn/html/202408003.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861303750426624 |
|---|---|
| author | WANG Xueling WANG Xueling ZHONG Peiling ZHONG Peiling ZHAO Zhipeng |
| author_facet | WANG Xueling WANG Xueling ZHONG Peiling ZHONG Peiling ZHAO Zhipeng |
| author_sort | WANG Xueling |
| collection | DOAJ |
| description | Objective To investigate the therapeutic efficacy of artesunate (AS) on polycystic ovary syndrome (PCOS) in mice and explore the potential mechanism primarily. Methods Twenty-five female C57BL/6J mice were randomly divided into Control group, model group (PCOS group), low- and high-dose AS groups (AS15 and AS30 groups) and metformin group (Met group). In addition to the Control group, the mouse model of PCOS was established by subcutaneous injection of dehydroepiandrosterone (DHEA, 60 mg/kg) following by a high-fat diet for 21 d. After modeling, AS of 15 and 30 mg/kg was intraperitoneally injected into the mice of the AS15 and AS30 groups, respectively, and 200 mg/kg Met was given to those of the Met group by gavage, once per day, for 6 weeks. ELISA was used to detect serum testosterone (T), fasting insulin (FINS), luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and the LH/FSH ratio was calculated. The levels of fasting blood glucose (FBG), triglyceride (TG) and total cholesterol (TC) were detected by automatic biochemical analyzer, and the homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. The estrous cycle was observed, and HE staining was performed for pathological changes in the ovary and uterus. Immunofluorescence assay was employed to measure the expression of p-eIF2α, ATF4 and CHOP in the ovarian tissue. After steroidogenic human granulosa-like tumor cell line KGN were exposed to 100 μmol/L DHEA to simulate the hyperandrogen environment of PCOS, and then treated with 5 and 10 μg/mL AS for 24 h, the protein levels of endoplasmic reticulum stress signaling pathway was detected by Western blotting. Results Compared with the Control group, the PCOS mice had disturbed estrous cycle, polycystic changes in the ovaries, and significantly increased serum T level and LH/FSH ratio (P<0.05), and obviously elevated HOMA-IR, TC and TG levels in terms of metabolism (P<0.01). The expression levels of p-eIF2α, ATF4 and CHOP were notably up-regulated in the ovarian granulosa cells of PCOS mice and KGN cells after DHEA exposure (P<0.05). Additionally, AS treatment attenuated the pathological changes of ovary and uterine expression, decreased the serum T level and the LH/FSH ratio (P<0.05), and reduced HOMA-IR, TC and TG levels (P<0.05) when compared with the PCOS mice. Moreover, the expression levels of p-eIF2α, ATF4 and CHOP were significantly down-regulated after AS treatment in both ovarian granulosa cells of PCOS mice and KGN cells (P<0.05). Conclusion AS significantly improves glycolipid metabolic disorder and reproductive dysfunction in PCOS mice, which may be associated with its suppressing endoplasmic reticulum stress by inhibiting the PERK/eIF2α/ATF4/CHOP pathway.
|
| format | Article |
| id | doaj-art-f57b711e85b44187bac2a1bac948a5de |
| institution | Kabale University |
| issn | 2097-0927 |
| language | zho |
| publishDate | 2025-02-01 |
| publisher | Editorial Office of Journal of Army Medical University |
| record_format | Article |
| series | 陆军军医大学学报 |
| spelling | doaj-art-f57b711e85b44187bac2a1bac948a5de2025-02-10T00:58:58ZzhoEditorial Office of Journal of Army Medical University陆军军医大学学报2097-09272025-02-0147319320410.16016/j.2097-0927.202408003Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndromeWANG Xueling0WANG Xueling1 ZHONG Peiling2 ZHONG Peiling3ZHAO Zhipeng4Reproductive Medicine Center， the First Affiliated Hospital of Chongqing Medical UniversityChongqing Key Laboratory of Biochemistry and Molecular PharmacologyChongqing Key Laboratory of Biochemistry and Molecular PharmacologyFaculty of Pharmacology， College of Pharmacy， Chongqing Medical University， Chongqing4 Department of Pathology， Qujing First People’s Hospital， Qujing， YunnanObjective To investigate the therapeutic efficacy of artesunate (AS) on polycystic ovary syndrome (PCOS) in mice and explore the potential mechanism primarily. Methods Twenty-five female C57BL/6J mice were randomly divided into Control group, model group (PCOS group), low- and high-dose AS groups (AS15 and AS30 groups) and metformin group (Met group). In addition to the Control group, the mouse model of PCOS was established by subcutaneous injection of dehydroepiandrosterone (DHEA, 60 mg/kg) following by a high-fat diet for 21 d. After modeling, AS of 15 and 30 mg/kg was intraperitoneally injected into the mice of the AS15 and AS30 groups, respectively, and 200 mg/kg Met was given to those of the Met group by gavage, once per day, for 6 weeks. ELISA was used to detect serum testosterone (T), fasting insulin (FINS), luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and the LH/FSH ratio was calculated. The levels of fasting blood glucose (FBG), triglyceride (TG) and total cholesterol (TC) were detected by automatic biochemical analyzer, and the homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. The estrous cycle was observed, and HE staining was performed for pathological changes in the ovary and uterus. Immunofluorescence assay was employed to measure the expression of p-eIF2α, ATF4 and CHOP in the ovarian tissue. After steroidogenic human granulosa-like tumor cell line KGN were exposed to 100 μmol/L DHEA to simulate the hyperandrogen environment of PCOS, and then treated with 5 and 10 μg/mL AS for 24 h, the protein levels of endoplasmic reticulum stress signaling pathway was detected by Western blotting. Results Compared with the Control group, the PCOS mice had disturbed estrous cycle, polycystic changes in the ovaries, and significantly increased serum T level and LH/FSH ratio (P<0.05), and obviously elevated HOMA-IR, TC and TG levels in terms of metabolism (P<0.01). The expression levels of p-eIF2α, ATF4 and CHOP were notably up-regulated in the ovarian granulosa cells of PCOS mice and KGN cells after DHEA exposure (P<0.05). Additionally, AS treatment attenuated the pathological changes of ovary and uterine expression, decreased the serum T level and the LH/FSH ratio (P<0.05), and reduced HOMA-IR, TC and TG levels (P<0.05) when compared with the PCOS mice. Moreover, the expression levels of p-eIF2α, ATF4 and CHOP were significantly down-regulated after AS treatment in both ovarian granulosa cells of PCOS mice and KGN cells (P<0.05). Conclusion AS significantly improves glycolipid metabolic disorder and reproductive dysfunction in PCOS mice, which may be associated with its suppressing endoplasmic reticulum stress by inhibiting the PERK/eIF2α/ATF4/CHOP pathway. https://aammt.tmmu.edu.cn/html/202408003.htmlartesunatepolycystic ovary syndromereproductive functionglycolipid metabolismendoplasmic reticulum stress |
| spellingShingle | WANG Xueling WANG Xueling ZHONG Peiling ZHONG Peiling ZHAO Zhipeng Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome 陆军军医大学学报 artesunate polycystic ovary syndrome reproductive function glycolipid metabolism endoplasmic reticulum stress |
| title | Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome |
| title_full | Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome |
| title_fullStr | Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome |
| title_full_unstemmed | Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome |
| title_short | Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome |
| title_sort | therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome |
| topic | artesunate polycystic ovary syndrome reproductive function glycolipid metabolism endoplasmic reticulum stress |
| url | https://aammt.tmmu.edu.cn/html/202408003.html |
| work_keys_str_mv | AT wangxueling therapeuticefficacyandmechanismofartesunateformousemodelofpolycysticovarysyndrome AT wangxueling therapeuticefficacyandmechanismofartesunateformousemodelofpolycysticovarysyndrome AT zhongpeiling therapeuticefficacyandmechanismofartesunateformousemodelofpolycysticovarysyndrome AT zhongpeiling therapeuticefficacyandmechanismofartesunateformousemodelofpolycysticovarysyndrome AT zhaozhipeng therapeuticefficacyandmechanismofartesunateformousemodelofpolycysticovarysyndrome |